US commits $3B to COVID-19 vaccine supply chain

The U.S. will invest $3 billion in the COVID-19 vaccine supply chain as a part of its efforts to scale up vaccine manufacturing, according to a Sept. 2 White House news briefing.

Advertisement

The funding will help drugmakers establish new production lines and facilities and expand fill and finish capacity.

“This $3 billion investment in our vaccine supply chain will create thousands of good-paying American jobs, help us deliver on the president’s commitment to be the arsenal of vaccines for the world, and strengthen our long-term capabilities to respond to future threats,” White House COVID-19 response coordinator Jeff Zients said.

The companies receiving the funding have not been selected yet, but the contracting process will “start across the next several weeks,” according to Mr. Zients.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.